Actually, the majority of mouse models with activating GOF PIK3CA mutations have been used to investigate various subtypes of breast cancer and their therapeutic strategies [77,78,79,96,124,125,132,164,171,172,173,175,176,177,178]. This evidence concerns the gene PIK3CA and breast cancer.